Showing results (1951-1960 of 2,547) with videos related to

Sort By:
Pageof 255
Transfusion|October 6, 1997
Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective studyJ K Preiksaitis, S Desai, W Vaudry, et al.
Developmental Medicine and Child Neurology|May 21, 1998
Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trialJ F McLaughlin, K F Bjornson, S J Astley, et al.
Journal of Feline Medicine and Surgery|June 11, 2015
Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trialJonathan N King, Stephen King, Steven C Budsberg, et al.
Pediatric Blood & Cancer|April 29, 2021
COVID-19 has changed the way we think about training future pediatric hematologists/oncologistsScott Moerdler, Bradley Gampel, Jennifer M Levine, et al.
Osteoarthritis and Cartilage|May 25, 2015
ADAMTS-4 activity in synovial fluid as a biomarker of inflammation and effusionS Roberts, H Evans, K Wright, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Native Top-Down Mass SpectrometryDavid S Roberts, Morgan W Mann, Jake A Melby, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|July 8, 2011
Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trialKaren L Kamholz, Dmitry Dukhovny, Haresh Kirpalani, et al.
Journal of Biophotonics|June 18, 2016
Visualizing liver anatomy, physiology and pharmacology using multiphoton microscopyHaolu Wang, Xiaowen Liang, Germain Gravot, et al.
Journal of the American Academy of Dermatology|April 10, 2022
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled studyChristopher Tehlirian, Ravi Shankar P Singh, Vivek Pradhan, et al.
The Journal of Infectious Diseases|December 23, 1999
Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivoK Kedzierska, J Mak, A Mijch, et al.
Pageof 255